Flc Capital Advisors Merck & Co., Inc. Transaction History
Flc Capital Advisors
- $441 Million
- Q1 2025
A detailed history of Flc Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Flc Capital Advisors holds 79,606 shares of MRK stock, worth $6.59 Million. This represents 1.62% of its overall portfolio holdings.
Number of Shares
79,606
Previous 79,026
0.73%
Holding current value
$6.59 Million
Previous $7.86 Million
9.11%
% of portfolio
1.62%
Previous 1.82%
Shares
25 transactions
Others Institutions Holding MRK
# of Institutions
3,899Shares Held
1.86BCall Options Held
16.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.07 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.66 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...